Hippocratic AI, a generative AI company developing safety-focused large language models for healthcare, has partnered with EUCALIA, a healthcare transformation company, to launch the first Japanese-language genAI healthcare agent for non-diagnostic, patient-facing clinical tasks. The…
Continue Reading
What You Should Know:
– Hippocratic AI, the global leader in safety-focused generative AI agents for healthcare, today announced a partnership with EUCALIA Inc., a Tokyo-based healthcare transformation company focused on optimizing clinical operations and…
Continue Reading
News
The UK’s health secretary says that AI-driven health checks – called MOTs for measurements, observations, and tests — could transform care for frail patients who are over 65 by using machine learning and genomics…
Continue Reading
Research from Japan has demonstrated the use of eye-tracking technology in the early diagnosis of autism spectrum disorder.Waseda University associate professor Mikimasa Omori set out to examine whether children with potential ASD would exhibit…
Continue Reading
What You Should Know:
– Shin Nippon Biomedical Laboratories, Ltd. (SNBL) and Tasso, Inc., a Seattle-based provider of patient-centric blood collection solutions, have announced an agreement to establish a new joint venture (JV) company.
– The…
Continue Reading
Vuno invests $2M, sells lung AI in Japan to rivalVuno has invested in and sold its lung disease diagnosis AI technology in Japan to its rival Korean company Coreline Soft.
The two companies recently entered…
Patient Satisfaction Study Reveals Groundbreaking Results
A landmark independent study published in the peer-reviewed journal Gland Surgery has revealed that breast cancer patients who underwent cryoablation treatment reported significantly higher satisfaction levels compared to those…
MediBuddy developing IoT devices with Japan’s ELECOMVirtual care company MediBuddy has started collaborating with Japanese electronics maker ELECOM to develop health IoT devices.
In a media release, MediBuddy said it will develop products for daily…
Groundbreaking AI Study Transforms Cancer Diagnostics
Lunit, in partnership with Japan’s National Cancer Center Hospital East (NCCHE), has published breakthrough research in the Journal of Clinical Oncology Precision Oncology. Their study demonstrates how AI-powered pathology…
Pathology software and services company Deciphex has closed its Series C financing, raising $32.3 million (£26.1m) to advance its mission to expand access to high-quality pathology through a technology-enabled global network of pathologists.
The funding…
